ACL Appoints New Group CEO
Key points
- New Group CEO Greg Horan appointed
- Effective from 31 August 2026
- Previous CEO Melinda McGrath steps down
- Horan brings extensive healthcare experience
Full summary
Australian Clinical Labs (ACL) has appointed Greg Horan as its new Group CEO and Executive Director, effective 31 August 2026. Horan, who joins as Group CEO-elect on 1 June 2026, brings 25 years of industry experience, most recently as CEO of Healthscope. Current CEO Melinda McGrath will step down after 10 years, during which ACL built a strong platform. ACL's Board Chair Stephen Roche and McGrath both expressed confidence in Horan's ability to lead the company forward.
Summary generated by a large language model. Please interpret with care.